ÂÜŔňÂŇÂ×

Kathrin C. Meyer, Ph.D., studied cellular and biomedical Sciences at the Institute of Cell Biology in Berne, Switzerland. Her postdoctoral research was performed in Brian Kaspar’s laboratory at the Center for Gene Therapy in Columbus, Ohio. During that time, Dr. Meyer established a new and fast reprogramming method for in vitro modeling of neurodegenerative diseases using patient skin cells. Moreover, Dr. Meyer developed intrathecal gene therapy programs for several neurodegenerative diseases, including Spinal Muscular Atrophy and Batten Disease. Multiple clinical trials that are based on this work are currently ongoing at Nationwide Children’s Hospital. In 2017, Dr. Meyer became a Principal Investigator at Nationwide Children’s Hospital. She is also an Assistant Professor in the Department of Pediatrics at The Ohio State University, Columbus, Ohio.